Healthcare - Biotechnology - NASDAQ - US
$ 1.77
-8.29 %
$ 78.9 M
Market Cap
-1.16
P/E
BALANCE SHEET
175 M
ASSETS
63.5 M
LIABILITIES
111 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Werewolf Therapeutics, Inc.
| Current Assets | 138 M |
| Cash & Short-Term Investments | 134 M |
| Receivables | 1.35 M |
| Other Current Assets | 2.68 M |
| Non-Current Assets | 36.5 M |
| Long-Term Investments | 0 |
| PP&E | 14.8 M |
| Other Non-Current Assets | 21.6 M |
| Current Liabilities | 19.4 M |
| Accounts Payable | 1.34 M |
| Short-Term Debt | 8.28 M |
| Other Current Liabilities | 9.77 M |
| Non-Current Liabilities | 44.1 M |
| Long-Term Debt | 43.6 M |
| Other Non-Current Liabilities | 433 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 134.3 | 129.3 | 157.5 | 92.6 | 17.9 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.4 | 6.9 | 0 | 0 | 0 |
| Inventory | 0 | 2 | 0 | 0 | 0 |
| Other Current Assets | 2.7 | 4.0 | 7.1 | 0.7 | 0.2 |
| Total Current Assets | 138.4 | 140.2 | 161.1 | 92.9 | 18.1 |
| PP&E | 14.8 | 17.5 | 16.3 | 3.1 | 3.4 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 1.2 | 1.2 | 0.2 | 0.2 |
| Other Long Term Assets | 21.6 | 1.4 | 0.6 | 0.2 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 174.8 | 160.2 | 179.2 | 96.4 | 21.7 |
| LIABILITIES | |||||
| Accounts Payable | 1.3 | 1.2 | 2.0 | 1.0 | 0.6 |
| Short Term Debt | 8.3 | 4.2 | 2.1 | 0.7 | 0.6 |
| Other Current Liabilities | 8.9 | 12.1 | 7.7 | 3.6 | 0.8 |
| Total Current Liabilities | 19.4 | 24.0 | 11.9 | 5.3 | 2.0 |
| Long Term Debt | 43.6 | 25.2 | 29.2 | 1.9 | 2.5 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | (12.4) | (14.6) | 141.1 | 41.4 |
| Total Liabilities | 63.5 | 37.9 | 26.5 | 148.3 | 46.0 |
| EQUITY | |||||
| Common Stock | 4 K | 3 K | 2 K | 2 K | 2 K |
| Retained Earnings | (344.1) | (306.7) | (252.9) | (51.9) | (24.4) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | (179.2) | (141.1) | (34.1) |
| Total Equity | 111.4 | 122.3 | 152.8 | (51.9) | (24.3) |
| Total Liabilities and Equity | 174.8 | 160.2 | 179.2 | 96.4 | 21.7 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 35.6 | 28.9 | 27.3 | 28.7 | 28.7 |